721. Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Toxicities: Poster II

Allogeneic hematopoietic stem cell transplantation for hematological malignancies using nonmyeloablative fludarabine, cyclophosphamide, 200 centigray total body irradiation, and post-transplant cyclophosphamide, sirolimus, and mycophenolate mofetil

Hematopoietic stem cell transplantation with reduced toxicity myeloablative conditioning regimen for children and adults with sickle cell disease A brazilian single center experience

Coronary artery calcification and its effect on cardiac events in patients undergoing allogeneic stem cell transplantation using nonmyeloablative conditioning

Tocilizumab for cytokine release syndrome after allogeneic hematopoietic stem cell transplantation with post transplant cyclophosphamide

Single center evaluation of TCRαβ T cell depletion using CliniMACS® plus platform Optimizing cell selection for hematopoietic stem cell transplantation

Real world data on the use of thrombopoietin receptor agonists in patients after allogeneic hematopoietic stem cell transplantation

Comparative efficacy of TBI based vs non TBI reduced toxicity conditioning regimens in adult ALL undergoing allogeneic HCT in CR1 Improved outcomes with TBI based RTC and ATG ptcy combination

The impact of cytokine release syndrome on survival following allogeneic stem cell transplantation with post transplantation cyclophosphamide Insights from real world data

Usefulness of C5b9 deposition analysis for the diagnosis treatment and monitoring of patients with transplant associated thrombotic microangiopathy

Real world outcomes of total body irradiation based conditioning in allogeneic hematopoietic stem cell transplantation A single center retrospective study

Ven FluBu2 with ptcy tac MMF RIC transplant followed by venetoclax azacitidine maintenance for high risk MDS AML

Blood microbial DNA as a non invasive diagnostic surrogate for pneumonia pathogens in immunocompromised patients A real world outcomes analysis

Diagnostic value of pathogen metagenomic next generation sequencing mNGS for early bloodstream infections in pediatric allogeneic hematopoietic stem cell transplantation recipients

Macrophage CD38 overexpression drives primary platelet engraftment failure via paracrine suppression following allogeneic hematopoietic stem cell transplantation

Establishing the impact of effective donor specific antibody DSA desensitisation in haploidentical and mismatched donor haematopoietic stem cell transplants An Australian experience

Secondary graft failure after PT cy Modeling a candidate risk assignment biomarker based on lymphocyte reconstitution   Results from the BMT CTN 1801 study

Characteristics and outcomes of pediatric hematopoietic stem cell transplantation associated thrombotic microangiopathy A retrospective single center analysis

Clinical characteristics of human herpesvirus 7 HHV 7 reactivation following umbilical cord blood transplantation A retrospective study

Young 35 years matched sibling donors for allogeneic transplantation with post transplantation cyclophosphamide in patients with secondary acute myeloid leukemia in first complete remission A study from the ALWP EBMT

Efficacy of thiotepa containing conditioning regimens and mucositis burden in allogeneic HSCT for relapsed refractory acute leukemia with extramedullary disease

TBI ATG based conditioning regimen is a promising approach for adult patients with refractory and relapsed peripheral T cell lymphoma undergoing allogeneic peripheral blood stem cell transplantation